Anthony Heng
Mary Gates Research Scholar
Autumn 2021
Project
Early Detection of Alpha Synuclein Toxic Oligomers in Parkinson’s Disease Patients
Lewy bodies are abnormal deposits of protein in the brain, and a pathogenic hallmark of Parkinson’s disease. They mostly consist of fibrillar ɑ-synuclein, an amyloidogenic protein. The Daggett lab investigates the involvement of a secondary structure called ɑ-sheet in amyloidogenic proteins, postulating that they adopt a nonstandard secondary structure called ɑ-sheet during aggregation upon forming soluble oligomers, prior to the formation of insoluble fibrils. This soluble, oligomeric species with ɑ-sheet secondary structure is the toxic agent in amyloidogenic diseases. Preliminary data reveal the presence of ɑ-sheet in Parkinson’s disease patient samples, showing promise for detection of Parkinson’s disease earlier than previously possible using an assay designed to detect proteins with ɑ-sheet secondary structure.